DailyIQ
|
DailyIQ
|
Last updated1 minute ago

ARDT·Ardent Health, Inc.

$11.95
+0.00 (+0.00%)
Market Closed (Overnight)$11.95+0.00 (+0.00%)
High
$0.00
Open
$0.00
Market Cap
1.69B
52W High
$15.48
Low
$0.00
P. Close
$11.95
P/E
21.55
52W Low
$7.71
Fwd P/E
9.52
DailyIQ Est.
-
Inst. Ownership
12.3%
Short Interest
3.28%
Days to Cover
10.7
NewEarnings release, scored · filed Aug 4, 2026Guidance reaffirmed · tone -21.9 vs prior release · 50 lines scoredSee the breakdown
Technical Score (1D)
15
BEARISH
News Sentiment
-
NO DATA
The 1D read on Ardent Health, Inc. (ARDT) is SELL at 15, a bottom-ranked momentum score. The stock has trailed most of the universe over the past year, excluding the latest month, and the bearish trend bias reflects that. Sentiment at 50 is diverging from the technical picture, which matters because sentiment can turn faster than a 12-month momentum rank. $11.22 is the level to hold; $12.16 is the first hurdle on any rebound. A bottom momentum rank reflects the prior year of trading, so it changes gradually even when the stock has a strong week. For near-term direction, price levels give the earlier read: a close back above $12.16 on real volume would be the first sign of repair, while a break of $11.22 keeps the bearish trend in charge.
ARDT|Analyst Targets
Bought (1Y)
0 shares
$0
Sold (1Y)
4,701 shares
$50K
Byers David RaynorSVP & Chief Accounting Officer
Tax Withholding524 shares2026-09-25
Petrovich Stephen C.EVP, GC and Secretary
Tax Withholding788 shares2026-09-25
LUMSDAINE ALFREDChief Financial Officer
Tax Withholding3,389 shares2026-09-25
View full insider trading history →
62/ 100
Neutral / mixed
Overall: Neutral
✓Revenue growing year over year
✓Positive net margin
✓Positive operating cash flow
Net Margin
2.1%
Revenue CAGR
7.2%
Current Ratio
1.97x
Debt / Equity
0.85x
Return on Equity
10.5%
View full financials →

EPS

EstBeatMiss
$0.16$0.35$0.54$0.73$0.92Q3'25Q3'26
QtrEstActual+/−
Q3'26$0.24 - -
Q3'25$0.42$0.83+95.9%

Revenue

EstBeatMiss
$1.6B$1.6B$1.6B$1.6B$1.6BQ3'25Q3'26
QtrEstActual+/−
Q3'26$1.6B - -
Q3'25 - $1.6B -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

ARDT Stock Snapshot

BEARISH15/100
$11.95+$0.00 (0.0%)
Market cap
1.69B
P/E ratio
21.6
Day range
$0.00 – $0.00
52-week range+55.0% off low · -22.8% from high
$7.71$15.48
Price $11.95

Price action on ARDT is defensive - rallies are being sold rather than extended. At this size, a single catalyst moves the stock further than it would a larger peer.

Sector Rotation

Is money rotating into or out of ARDT's sector?

Ardent Health, Inc. sits in the Health Care sector, currently ranked 3rd of 12 GICS sectors by relative-strength rotation score (leading).

Sector rank
#3 of 12
Sector state
Leading
Sector rotation score
82

Options Market

What is the options market pricing for ARDT?

CallsPuts

For Ardent Health, Inc.'s nearest expiry (2026-11-20, 33 days out), open interest is call-heavy, a bullish tilt (put/call ratio of 0.09), with at-the-money implied volatility around 65.6%. The options market is pricing roughly a ±21.6% move by that expiry — a range of about $9.37–$14.53.

Put/call ratio (2026-11-20)
0.09
ATM implied volatility
65.6%
Total open interest
243
Expected move by 2026-11-20
±21.6% ($9.37–$14.53)

Corporate Stakes

Which companies own a stake in ARDT?

6.62%held by VTR

Ventas, Inc. reports a stake in Ardent Health, Inc. on SEC Form 13F: 9.3M shares, about 6.62% of the company, worth $91.9M at the end of Q2 2026. At today's price that stake is worth $111.6M, about 0.25% of VTR's own market value.

Holder
VTR
Shares held
9.3M
Stake
6.62%
Value
$91.9M
HolderLast quarterShares% of ARDTValue at filingValue now
Ventas, Inc. VTRUnchanged9.3M6.62%$91.9M$111.6M

Form 13F lists US-listed shares held at quarter-end and is filed up to 45 days later. Stakes in private companies are not on it.

Earnings Release, Scored

What did Ardent Health, Inc.'s latest earnings release say?

Filed Aug 4, 2026 · SEC Form 8-K, Exhibit 99

Guidance reaffirmed
Tone49.2/ 100-21.9 vs prior release
Hedging words0.15per 100 words-0.18 vs prior release
Tone, last 2 releasesScale 44–77

Most important lines

  1. 1

    "Those actions included an improved payor contract in a key market and incremental benefit from our IMPACT program, which we now expect to generate at least $70 million of savings in 2026, compared with $55 million previously.

    Guidance raisedNew this quarter
  2. 2

    Adjusted EBITDA decreased 32.3% year-over-year to $115 million .

    New this quarterNegative tone
  3. 3

    Additionally, we reported strong second quarter operating cash flow of $197 million ." • "Our actions give us confidence to reaffirm our 2026 Adjusted EBITDA guidance of $485 million to $535 million , even as we factor in a lower volume outlook," Caspers said.

    Guidance reaffirmedNew this quarter

Scores describe the release's wording. They are not a forecast.

Read all 50 scored lines →

News & sentiment

What is the news saying about ARDT?

ARDT rose 11.5% over the month to Oct 16. Daily news tone ranged from 50 to 50 and read 50 on Oct 15.

Daily close and news tone, Sep 16 to Oct 16
$11$12Sep 16Sep 17Sep 18Sep 21Sep 22Sep 23Sep 24Sep 25Sep 28Sep 29Sep 30Oct 1: tone 50Oct 2Oct 5Oct 6Oct 7Oct 8Oct 9Oct 12Oct 13Oct 14Oct 15: tone 50Oct 16Sep 16News toneOct 16123
  1. Sep 22 +3.2%
  2. Sep 23 -2.8%same day: BMO Capital Initiates Ardent Health With Market Perform Rating, $11 Price Target
  3. Oct 8 +2.3%
Latest stories naming Ardent Health

Technical analysis

How strong is ARDT's momentum right now?

On the daily chart ARDT ranks at the 15th percentile for momentum against 1,057 stocks and ETFs, a bearish reading.

Momentum rank by timeframe0 = weakest, 100 = strongest
See what drives the rankThe inputs behind each timeframe's momentum rank, plus RSI, stochastics, Bollinger Bands and moving averages. Free with an account.

Institutional ownership

Are big funds buying or selling ARDT?

29 of the 52 tracked managers added to ARDT in their latest 13F and 21 trimmed. Together they own 5.7% of the company, worth $78.7M. Ameriprise Financial and Vanguard Capital Management alone hold 2.2%.

29adding21trimming2unchanged
Largest holders by stake, latest 13FBar = share of ARDT
  1. 1Ameriprise Financial Inc1.50%
    $20.8M positionAdded 18.8% last quarter
  2. 2Vanguard Capital Management LLC0.68%
    $9.5M positionTrimmed 4.4% last quarter
  3. 3State Street Corp0.40%
    $5.6M positionTrimmed 3.4% last quarter
  4. 4First Trust Advisors LP0.40%
    $5.5M positionAdded 17.4% last quarter
  5. 5Hotchkis & Wiley Capital Management LLC0.32%
    $4.4M positionAdded 0.5% last quarter
  6. 6UBS Group AG0.31%
    $4.4M positionTrimmed 1.8% last quarter
  7. 7American Century Companies Inc0.22%
    $3.0M positionAdded 460.5% last quarter
  8. 8Jane Street Group, LLC0.21%
    $3.0M positionAdded 54.8% last quarter
  9. 9Bank of New York Mellon Corp0.17%
    $2.4M positionAdded 0.2% last quarter
  10. 10Vanguard Portfolio Management LLC0.15%
    $2.0M positionTrimmed 25.5% last quarter
Full holdings history

Discover more

How has ARDT done against its peers?

Over the month to Oct 16, ARDT returned +11.8%. Of the 15 related stocks and ETFs, 1 did better, led by AMGN at +14.9%.

Change since Sep 15Through Oct 16
−10%−5%0%+5%+10%+15%+20%Sep 15Oct 16AMGN +14.9%ARDT +11.8%JNJ −3.6%